The results of the HIV (human immunodeficiency virus) experiment and compare them with the Ebola virus (EBOV) experiment. Introduction: Ebola virus can lead to severe and fatal hemorrhagic fever in the human beings. The disease caused is known as Ebola virus disease. HIV is the subgroup of retrovirus (lentivirus) that leads to AIDS (acquired immunodeficiency syndrome). HIV utilizes CD4 (cluster of differentiation 4) receptor in order to enter the T helper cells. The cells that have free and unbound CD4 on their surface will be infected by the HIV. CD4 is a membrane protein that HIV utilizes to enter the cells. Similarly, researchers have identified many surface proteins that may work as a virus receptor for the EBOV. The figure below shows the experiment that was performed using HIV virus. Experiment: One hundred sixty identical samples of T helper cells were grown in the culture. Different antibodies were then added into each sample of the cells. The antibody inhibits the specific membrane protein. A constant number of virions were then added to the samples followed by the incubation process under the conditions that are optimal for the viruses to enter.

Question

Want to see the full answer?

Answer 1

Question

Chapter 33, Problem 12PIAT

Summary Introduction

To review:

The results of the HIV (human immunodeficiency virus) experiment and compare them with the Ebola virus (EBOV) experiment.

Introduction:

Ebola virus can lead to severe and fatal hemorrhagic fever in the human beings. The disease caused is known as Ebola virus disease. HIV is the subgroup of retrovirus (lentivirus) that leads to AIDS (acquired immunodeficiency syndrome). HIV utilizes CD4 (cluster of differentiation 4) receptor in order to enter the T helper cells. The cells that have free and unbound CD4 on their surface will be infected by the HIV. CD4 is a membrane protein that HIV utilizes to enter the cells. Similarly, researchers have identified many surface proteins that may work as a virus receptor for the EBOV. The figure below shows the experiment that was performed using HIV virus.

Experiment: One hundred sixty identical samples of T helper cells were grown in the culture. Different antibodies were then added into each sample of the cells. The antibody inhibits the specific membrane protein. A constant number of virions were then added to the samples followed by the incubation process under the conditions that are optimal for the viruses to enter.

Expert Solution & Answer

Want to see the full answer?

Check out a sample textbook solution

See solution

Students have asked these similar questions

Which of the following could not be used a a host cell receptor for viral entry? a.) LPS on bacterial cells b.) Surface glycoproteins on human cells c.)Flagella d.) Ribosomes

1. Precise words:Find the nonspecific terms in the following sentences. Replace the nonspecific choices with more preciseterms or phrases (It is not necessary to change the sentence structure).(i) All OVE mutants showed enhanced iP concentrations.(ii) Plants were kept in the cold overnight.(iii) To provide proof of concept for our hypothesis, we studied a virus in its host cell.(iv) The present paper reports on continuing experiments that were performed to clarify thissurprising effect.(v) The first transition state is a little lower in energy than the second transition state. 2. Simple words:Improve the word choice in the following examples by replacing the underlined terms or phrases withsimpler word choices (do not change the sentence structure).(i) These data substantiate our hypothesis.(ii) The difference in our results compared to those of Reuter et al. (1995) can be accounted forby the fact that different conditions were used.(iii) For the purpose of discussing cell migration we…

Moderna and Pfizer vaccines for COVID-19 use mRNA to the Spike protein combined with lipids. Which of the following is/are advantages of this type of vaccine compared to an inactivated virus vaccine? Select ALL correct answers. a) The vaccine is more stable for transport. b) The vaccine does not contain the virus so it cannot give you COVID-19. c) The vaccine can be rapidly produced in a slightly different form to protect from variants of SARS-CoV-2. d) The vaccine does not need a booster.